Low-density Lipoprotein Receptor Activity in Cultured Human Skin Fibroblasts. Mechanism of Insulin-induced Stimulation
Overview
Authors
Affiliations
Low-density lipoproteins (LDL) receptor activity, as reflected by LDL degradation, was stimulated by the addition of insulin to cultures of human skin fibroblasts. These changes occurred independently of the glucose concentration of the incubation medium and occurred whether or not LDL receptor activity was suppressed. A comparison of the saturation kinetics of LDL receptor activity in the presence and absence of insulin indicated that insulin produced a 35% increase in Vmax with no difference in "apparent Km". These results suggest that insulin enhances LDL receptor activity by increasing the number of LDL receptors rather than by influencing binding affinity. In confirmation, LDL degradation by receptor negative cells was not enhanced by insulin. Sterol synthesis from [14C]acetate was also stimulated by insulin, but egress of cholesterol and cellular cholesterol content were unaffected by the hormone. The effect of insulin on LDL receptors was not dependent on its known ability to enhance cellular DNA synthesis and proliferation, because insulin stimulated LDL receptor activity in cells kept quiescent by maintenance in plasma-derived serum that was devoid of platelet derived growth factor. Nevertheless, the effect of insulin in enhancing LDL receptor number, coupled with stimulation of endogenous cholesterol synthesis, provides a mechanism whereby the cell could theoretically increase its supply of cholesterol during times of additional need.
Markus M, Weiss F, Hertel J, Weiss S, Ruhlemann M, Bang C Sci Rep. 2025; 15(1):5171.
PMID: 39939328 PMC: 11822121. DOI: 10.1038/s41598-025-88415-4.
Ultraprocessed food consumption and risk of gallstone disease: analysis of 3 prospective cohorts.
Uche-Anya E, Ha J, Khandpur N, Rossato S, Wang Y, Nguyen L Am J Clin Nutr. 2024; 120(3):499-506.
PMID: 38971469 PMC: 11393404. DOI: 10.1016/j.ajcnut.2024.07.002.
Physical activity and risk of gallstone disease: A Mendelian randomization study.
Qian Q, Jiang H, Cai B, Chen D, Jiang M Front Genet. 2022; 13:943353.
PMID: 36561321 PMC: 9763559. DOI: 10.3389/fgene.2022.943353.
Pelletier R, Layeghkhavidaki H, Seidah N, Prat A, Vitale M Front Cell Dev Biol. 2022; 10:889972.
PMID: 35586340 PMC: 9108277. DOI: 10.3389/fcell.2022.889972.
The Theory of Hyperlipidemic Memory of Type 1 Diabetes.
Nwosu B Front Endocrinol (Lausanne). 2022; 13:819544.
PMID: 35432186 PMC: 9009047. DOI: 10.3389/fendo.2022.819544.